![](/img/cover-not-exists.png)
Effects of the dual sodiumâglucose linked transporter inhibitor, licogliflozin versus placebo or empagliflozin in patients with type 2 diabetes and heart failure
Boer, Rudolf A., Núñez, Julio, Kozlovski, Plamen, Wang, Yi, Proot, Pieter, Keefe, DeborahJournal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.14248
Date:
February, 2020
File:
PDF, 1.25 MB
2020